FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Monovoukas Yiannis 2. Date of Event Requiring Statement (MM/DD/YYYY)
3/25/2021 

3. Issuer Name and Ticker or Trading Symbol Brooklyn ImmunoTherapeutics, Inc. [BTX]
(Last)       (First)       (Middle)
140 58TH STREET, BUILDING A, SUITE 2100
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)
BROOKLYN, NY 11220      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  560453  I  By The Yiannis Monovoukas Family 2013 Irrevocable Trust FBO Alexi Monovoukas 
Common Stock  560453  I  By The Yiannis Monovoukas Family 2013 Irrevocable Trust FBO Aresti Monovoukas 
Common Stock  560453  I  By The Yiannis Monovoukas Family 2013 Irrevocable Trust FBO Christian Monovoukas 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Monovoukas Yiannis
140 58TH STREET, BUILDING A, SUITE 2100
BROOKLYN, NY 11220
X



Signatures
/s/ Mark L. Johnson, Attorney-in-Fact for Yiannis Monovoukas 4/16/2021
**Signature of Reporting Person Date